Comparative analysis of 3D-culture techniques for multicellular colorectal tumour spheroids and development of a novel SW48 3D-model
- PMID: 40731083
- PMCID: PMC12307937
- DOI: 10.1038/s41598-025-13588-x
Comparative analysis of 3D-culture techniques for multicellular colorectal tumour spheroids and development of a novel SW48 3D-model
Abstract
Colorectal cancer (CRC) is an important global health challenge, with nearly 2 million diagnosed cases and over 900,000 deaths annually despite therapeutic advancements. The high morbidity and mortality rates underscore the need for more efficient therapies. Three-dimensional (3D) cell culture models have emerged as more physiologically relevant alternatives to traditional two-dimensional (2D) models for drug screening and mechanistic studies. However, generating consistent spheroids across different CRC cell lines presents technical challenges, and protocols remain inconsistent. This study evaluated different 3D culture methodologies, i.e. overlay on agarose, hanging drop, and U-bottom plates without matrix or with methylcellulose, Matrigel or collagen type I hydrogels, across eight CRC cell lines. Multicellular tumour spheroids (MCTS) morphology and cell viability were analysed. Co-cultures with immortalised colonic fibroblasts were explored to improve the physiological relevance of the tumour models. The study provided insights into the morphological and viability characteristics of 3D cultures across multiple CRC cell lines. A novel compact spheroid model using the SW48 cell line was successfully developed. Co-culture experiments with fibroblasts offered additional insights into tumour-stroma interactions in a 3D setting. This study contributes to the advancement of more physiologically relevant in vitro CRC models, potentially enhancing the accuracy of preclinical studies and drug screening processes. The successful 3D model of SW48 expands the repertoire of CRC cell lines available for 3D culture studies. The treatment of regular multi-well plates with anti-adherence solution allows to generate CRC spheroids at significantly lower cost than using cell-repellent multi-well plates. These findings may lead to improved preclinical models for CRC research and drug development.
Keywords: Colorectal cancer 3D models; Tumour spheroids.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Consent for publication: All authors have read and agreed to the published version of the manuscript. Competing interests: The authors declare no competing interests.
Figures








Similar articles
-
Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.J Cancer Res Clin Oncol. 2017 Sep;143(9):1771-1786. doi: 10.1007/s00432-017-2434-2. Epub 2017 May 11. J Cancer Res Clin Oncol. 2017. PMID: 28497169 Free PMC article.
-
Matrix Stiffness and Biochemistry Govern Colorectal Cancer Cell Growth and Signaling in User-Programmable Synthetic Hydrogels.ACS Biomater Sci Eng. 2025 May 12;11(5):2810-2823. doi: 10.1021/acsbiomaterials.4c01632. Epub 2025 Apr 30. ACS Biomater Sci Eng. 2025. PMID: 40304602
-
Development of tetraculture spheroids as a versatile 3D model for personalized breast cancer research.Sci Rep. 2025 Jul 28;15(1):27449. doi: 10.1038/s41598-025-12556-9. Sci Rep. 2025. PMID: 40721466 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
References
-
- Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut72, 338–344 (2023). - PubMed
-
- Schmoll, H. J. et al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann. Oncol.23, 2479–2516 (2012). - PubMed
-
- Van Cutsem, E. et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol.27, 1386–1422 (2016). - PubMed
-
- Araghi, M. et al. Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut70, 114–126 (2021). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical